Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza

BACKGROUND: Danirixin (DNX), a selective and reversible CXC chemokine receptor 2 antagonist, inhibits neutrophil transmigration and activation. This study assessed the safety, tolerability, and clinical effect of DNX with and without oseltamivir (OSV) in adults with acute, uncomplicated influenza. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Grace, Chen, Shuguang, Yates, Phillip, Madan, Anuradha, Walker, Jill, Washburn, Michael L, Peat, Andrew J, Soucie, Gary, Kerwin, Edward, Roy-Ghanta, Sumita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476494/
https://www.ncbi.nlm.nih.gov/pubmed/31024969
http://dx.doi.org/10.1093/ofid/ofz072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476494/
https://www.ncbi.nlm.nih.gov/pubmed/31024969
http://dx.doi.org/10.1093/ofid/ofz072

Ejemplares similares